MedPath

Diclofenac Sodium Extended-Release

DICLOFENAC SODIUM EXTENDED-RELEASE TABLETS, USP

Approved
Approval ID

688fa1d0-6e17-4191-8618-8f62bc7765d3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 1, 2009

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diclofenac Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-040
Application NumberANDA075910
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diclofenac Sodium
Product Specifications
Route of AdministrationORAL
Effective DateJune 1, 2009
FDA Product Classification

INGREDIENTS (11)

colloidal silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
Diclofenac SodiumActive
Quantity: 100 mg in 1 1
Code: QTG126297Q
Classification: ACTIM
carnauba waxInactive
Code: R12CBM0EIZ
Classification: IACT
hypromelloseInactive
Code: 3NXW29V3WO
Classification: IACT
povidoneInactive
Code: FZ989GH94E
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT
cetyl alcoholInactive
Code: 936JST6JCN
Classification: IACT
lactose monohydrateInactive
Code: EWQ57Q8I5X
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.